4//SEC Filing
MAHON PAUL A 4
Accession 0001231589-26-000001
CIK 0001082554other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:30 PM ET
Size
23.0 KB
Accession
0001231589-26-000001
Insider Transaction Report
Form 4
MAHON PAUL A
EVP & GENERAL COUNSEL
Transactions
- Exercise/Conversion
Common Stock
2026-01-02$146.03/sh+8,300$1,212,049→ 45,081 total - Sale
Common Stock
2026-01-02$481.26/sh−822$395,595→ 44,259 total - Sale
Common Stock
2026-01-02$481.83/sh−479$230,797→ 43,780 total - Sale
Common Stock
2026-01-02$483.35/sh−739$357,195→ 43,041 total - Sale
Common Stock
2026-01-02$484.54/sh−1,240$600,825→ 41,801 total - Sale
Common Stock
2026-01-02$485.68/sh−1,509$732,894→ 40,292 total - Sale
Common Stock
2026-01-02$486.85/sh−1,130$550,136→ 39,162 total - Sale
Common Stock
2026-01-02$487.76/sh−2,181$1,063,803→ 36,981 total - Sale
Common Stock
2026-01-02$489.15/sh−200$97,830→ 36,781 total - Exercise/Conversion
Stock Option
2026-01-02−8,300→ 66,700 totalExercise: $146.03From: 2020-03-15Exp: 2027-03-15→ Common Stock (8,300 underlying)
Footnotes (9)
- [F1]This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $480.64 to $481.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $481.66 to $482.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $482.87 to $483.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $484.14 to $485.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $485.39 to $486.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F7]This transaction was executed in multiple trades at prices ranging from $486.51 to $487.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F8]This transaction was executed in multiple trades at prices ranging from $487.51 to $488.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F9]This transaction was executed in multiple trades at prices ranging from $489.06 to $489.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
UNITED THERAPEUTICS Corp
CIK 0001082554
Entity typeother
Related Parties
1- filerCIK 0001231589
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 4:30 PM ET
- Size
- 23.0 KB